Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open Angle Glaucoma or Ocular Hypertension”

350 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 350 results

Testing effectiveness (Phase 2)Study completedNCT01915940
What this trial is testing

Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 169
Testing effectiveness (Phase 2)Study completedNCT03310580
What this trial is testing

Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle Glaucoma or Ocular Hypertension
Aerie Pharmaceuticals 42
Large-scale testing (Phase 3)Study completedNCT02059278
What this trial is testing

Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Nephron Pharmaceuticals Corporation 335
Not applicableActive Not RecruitingNCT07154810
What this trial is testing

Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination

Who this might be right for
GlaucomaCataractOcular Hypertension
SpyGlass Pharma, Inc. 23
Not applicableStudy completedNCT01632423
What this trial is testing

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 10,337
Large-scale testing (Phase 3)Study completedNCT00928590
What this trial is testing

Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 155
Post-approval studies (Phase 4)Study completedNCT01327599
What this trial is testing

Efficacy of Changing to DUOTRAV® From Prior Therapy

Who this might be right for
Open-Angle GlaucomaOcular HypertensionPigment Dispersion Glaucoma
Alcon Research 60
Not applicableStudy completedNCT01068964
What this trial is testing

Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Allergan 235
Testing effectiveness (Phase 2)Study completedNCT01528111
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-angle GlaucomaOcular Hypertension
Lexicon Pharmaceuticals 63
Testing effectiveness (Phase 2)Study completedNCT02014142
What this trial is testing

Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
Ocular HypertensionOpen-Angle Glaucoma
Mati Therapeutics Inc. 86
Testing effectiveness (Phase 2)Study completedNCT00868894
What this trial is testing

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Santen Inc. 49
Large-scale testing (Phase 3)Study completedNCT00159653
What this trial is testing

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500
Large-scale testing (Phase 3)Study completedNCT01895972
What this trial is testing

Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT

Who this might be right for
GlaucomaOcular Hypertension
Bausch & Lomb Incorporated 130
Large-scale testing (Phase 3)Study completedNCT00293800
What this trial is testing

Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 173
Large-scale testing (Phase 3)Study completedNCT00288951
What this trial is testing

Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 690
Post-approval studies (Phase 4)Study completedNCT00759239
What this trial is testing

Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 36
Testing effectiveness (Phase 2)Study completedNCT00657579
What this trial is testing

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT01342094
What this trial is testing

DE-111 Against Timolol Ophthalmic Solution 0.5%

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 166
Testing effectiveness (Phase 2)Study completedNCT02250612
What this trial is testing

SYL040012, Treatment for Open Angle Glaucoma

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Sylentis, S.A. 184
Testing effectiveness (Phase 2)Study completedNCT01739244
What this trial is testing

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Who this might be right for
Ocular HypertensionOpen Angle Glaucoma
Sylentis, S.A. 80
Load More Results